Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer-Single-Center Experience.
diagnostics
electrophoresis
high-molecular weight multimers (HMW)
intermediate-molecular weight multimers (IMW)
low-molecular weight multimers (LMW)
von Willebrand disease
von Willebrand factor
von Willebrand factor multimers
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
20 Nov 2021
20 Nov 2021
Historique:
received:
11
10
2021
revised:
15
11
2021
accepted:
16
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and/or deficiency of the plasma protein von Willebrand factor (VWF). Laboratory testing for VWF-related disorders requires the assessment of both VWF level and VWF activity, the latter requiring multiple assays. As an additional step, an evaluation of VWF structural features by multimer analysis is useful in selective investigations. Multimer analysis is also important for the selection of a suitable VWF therapy preparation (desmopressin, VWF/FVIII concentrate, recombinant VWF) and the determination of the correct dose for the patient. Based on clinical and laboratory findings, including the analysis of VWF multimers, we classified our patients into individual types of VWD. Our study group included 58 patients. The study group consisted of 66% (38 patients) with VWD type 1, 5% (3 patients) with VWD type 2, 7% (4 patients) with VWD type 3, 5% (3 patients) with mixed type 1/2A VWD, and 17% (10 patients) comprising an unclassified group. In this article, we provide an overview of our practical experience using a new complementary method-the analysis of von Willebrand factor multimers with a semi-automatic analyzer Hydrasys 2 scan. We explain the principle, procedure, advantages, and pitfalls associated with the introduction of the VWF multimer analysis methodology into standard VWD diagnostics.
Identifiants
pubmed: 34829500
pii: diagnostics11112153
doi: 10.3390/diagnostics11112153
pmc: PMC8621170
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S3-S10
pubmed: 15849525
Res Pract Thromb Haemost. 2020 Jul 16;4(6):1024-1034
pubmed: 32864553
Blood Transfus. 2016 May;14(2):262-76
pubmed: 27136426
Semin Thromb Hemost. 2017 Sep;43(6):639-641
pubmed: 28609796
Semin Thromb Hemost. 2020 Jun;46(4):484-500
pubmed: 31887760
PLoS One. 2017 Jun 22;12(6):e0179566
pubmed: 28640903
Int J Lab Hematol. 2019 Dec;41(6):762-771
pubmed: 31508897
J Thromb Haemost. 2013 Jun;11 Suppl 1:192-201
pubmed: 23809123
Best Pract Res Clin Haematol. 2001 Jun;14(2):299-319
pubmed: 11686101
Ann Blood. 2018 Jan;3:
pubmed: 30135959
Semin Thromb Hemost. 2011 Jul;37(5):440-55
pubmed: 22102186
Semin Thromb Hemost. 2016 Mar;42(2):133-46
pubmed: 26838696
Blood. 2000 Mar 15;95(6):2000-7
pubmed: 10706867
Haemophilia. 2008 Mar;14(2):171-232
pubmed: 18315614
Ann Transl Med. 2018 Sep;6(17):345
pubmed: 30306084
J Clin Lab Anal. 2018 Jul;32(6):e22416
pubmed: 29453814
Mayo Clin Proc. 2006 May;81(5):679-91
pubmed: 16706266
Hemasphere. 2021 Feb 17;5(3):e542
pubmed: 33623884
Hamostaseologie. 2014;34(3):215-25
pubmed: 25010251
Hematology Am Soc Hematol Educ Program. 2009;:106-12
pubmed: 20008188
Res Pract Thromb Haemost. 2018 Aug 12;2(4):790-799
pubmed: 30349898
Semin Thromb Hemost. 2014 Feb;40(1):17-27
pubmed: 24338608
Br J Haematol. 2014 Nov;167(4):453-65
pubmed: 25113304
Int J Lab Hematol. 2018 Oct;40(5):586-591
pubmed: 29920949
Blood Adv. 2021 Jan 12;5(1):280-300
pubmed: 33570651
Clin Chem Lab Med. 2014 Sep;52(9):1273-6
pubmed: 24945431
Blood. 2014 Jun 26;123(26):4143-51
pubmed: 24700780